Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Shire Human Genetic Therapies patents TGF-beta inhibitors

Aug. 28, 2018

Galecto Biotech compound is an orally available drug for fibrosis and cancer

Aug. 28, 2018

Discovery of a novel, orally available, transient receptor potential channel 6 inhibitor

Aug. 28, 2018

Cathepsin S inhibitors discovered at Astellas

Aug. 23, 2018

GNE-684: a potent inhibitor of RIPK1 for treating inflammatory diseases due to dysregulated NEMO

Aug. 22, 2018

Principia Biopharma patents proteasome subunit beta type-8/beta type-9 inhibitors

Aug. 17, 2018

MAP3K5 inhibitors identified by Fujian Cosunter Pharmaceutical Co., Medshine Discovery

Aug. 13, 2018

Uncovering the function of Cep57 in mosaic-variegated aneuploidy syndrome

Aug. 13, 2018

BRD4 inhibitors patented by Luoxin Biotechnology Shanghai, Shandong Luoxin Pharmacy Group

July 30, 2018

Vasopressin inhibition decreases mortality in jet-lagged mice

July 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...